(PDF) Molecular Context of the EGFR Mutations: Evidence for

Molecular Context of the EGFR Mutations: Evidence for the Activation of mTOR/S6K Signaling

Clinical Cancer Research - United States

doi 10.1158/1078-0432.ccr-05-1362

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

February 1, 2006

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

AXL Circumvents PI3K Inhibition by Activating EGFR-PKC-mTOR Signaling

Cancer Discovery

English

A Functional Analysis of the Drosophila Gene Hindsight: Evidence for Positive Regulation of EGFR Signaling

G3: Genes, Genomes, Genetics

Molecular Biology

English

Activation of AKT-mTOR Signaling Directs Tenogenesis of Mesenchymal Stem Cells

Molecular Medicine

Developmental Biology

English

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2

Cancer Research

English

Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation

Cancer Research

Molecular Biology

English

Activation of the BMP-BMPR Pathway Conferred Resistance to EGFR-TKIs in Lung Squamous Cell Carcinoma Patients With EGFR Mutations

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Altered Conformational Landscape and Dimerization Dependency Underpins the Activation of EGFR byαC–β4 Loop Insertion Mutations

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and Myofibroblasts

Multidisciplinary

English

Regulation of Insulin Signalling by Hyperinsulinaemia: Role of IRS-1/2 Serine Phosphorylation and the mTOR/p70 S6K Pathway

Internal Medicine

English